Newron Pharmaceuticals (NWPHF) News Today → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Free NWPHF Stock Alerts $11.40 0.00 (0.00%) (As of 05/14/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 13 at 11:15 AM | finance.yahoo.comNewron Reports Compelling Additional Data Documenting the Efficacy of Evenamide in Pivotal Study 008A in Poorly Responding Schizophrenia PatientsApril 8, 2024 | finance.yahoo.comData from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS)March 19, 2024 | finance.yahoo.comNewron Presents 2023 Financial Results and Provides 2024 OutlookMarch 15, 2024 | finance.yahoo.comNewron announces agreement with the European Investment Bank (EIB) to extend the near-term tranche repayment dates of its 2018 financing agreementMarch 13, 2024 | finance.yahoo.comBreakeven Is Near for Newron Pharmaceuticals S.p.A. (VTX:NWRN)January 4, 2024 | finance.yahoo.comNewron Reports Exceptional One-year Results of Study 014/15 With Evenamide in Treatment-resistant Schizophrenia (TRS)January 2, 2024 | msn.comNewron enrols all subjects in schizophrenia treatment trialDecember 29, 2023 | markets.businessinsider.comEQS-News: Newron completes enrollment of schizophrenia patients in potentially pivotal study 008A with EvenamideDecember 13, 2023 | morningstar.comNewron Pharmaceuticals SpA NWRNOctober 9, 2023 | finance.yahoo.comNewron TRS Study 6 Months’ Results: Evenamide Substantially Improves Patients to an Extent That They No Longer Meet Protocol Entry CriteriaOctober 4, 2023 | businesswire.comNewron to Present Three Posters on Its Clinical Program Evaluating Evenamide in the Treatment of Schizophrenia at the 36 th European College of Neuropsychopharmacology CongressOctober 4, 2023 | finance.yahoo.comNewron to Present Three Posters on Its Clinical Program Evaluating Evenamide in the Treatment of Schizophrenia at the 36th European College of Neuropsychopharmacology CongressOctober 2, 2023 | markets.businessinsider.comEQS-News: Newron appoints Margarita Chavez as board advisorOctober 2, 2023 | finance.yahoo.comNewron Appoints Margarita Chavez as Board AdvisorAugust 4, 2023 | finance.yahoo.comNewron Announces H1 2023 Results and Provides R&D UpdateAugust 4, 2023 | markets.businessinsider.comEQS-News: Newron announces H1 2023 results and provides R&D updateJune 15, 2023 | finance.yahoo.comInvesting in Newron Pharmaceuticals (VTX:NWRN) a year ago would have delivered you a 187% gainMay 2, 2023 | markets.businessinsider.comEQS-News: Newron announces Senior Management Team changesMay 2, 2023 | uk.finance.yahoo.comNewron announces Senior Management Team changesApril 27, 2023 | finance.yahoo.comAnalysts Expect Newron Pharmaceuticals S.p.A. (VTX:NWRN) To Breakeven SoonApril 18, 2023 | uk.finance.yahoo.comNewron announces AGM 2023 resultsApril 18, 2023 | markets.businessinsider.comEQS-News: Newron announces AGM 2023 resultsMarch 28, 2023 | markets.businessinsider.comEQS-News: Newron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of PsychiatryMarch 28, 2023 | uk.finance.yahoo.comNewron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of PsychiatryMarch 17, 2023 | markets.businessinsider.comEQS-News: Newron to present at the 31st European Congress of PsychiatryMarch 14, 2023 | uk.finance.yahoo.comNewron announces 2022 financial results and provides outlook for 2023February 13, 2023 | msn.comNewron: Managing India’s Next-gen of Modern SchoolsJanuary 6, 2023 | ca.finance.yahoo.comNewron Pharmaceuticals (VTX:NWRN) soars 117% this week, taking one-year gains to 104%December 22, 2022 | wsj.comNewron Pharmaceuticals S.p.A.October 31, 2022 | finance.yahoo.comAnalysts Expect Breakeven For Newron Pharmaceuticals S.p.A. (VTX:NWRN) Before LongSeptember 15, 2022 | uk.finance.yahoo.comNewron provides H1 2022 results and updates on R&D and business activitiesSeptember 15, 2022 | uk.finance.yahoo.comNewron provides H1 2022 results and updates on R&D and business activitiesSeptember 15, 2022 | markets.businessinsider.comDGAP-News: Newron provides H1 2022 results and updates on R&D and business activitiesJuly 1, 2022 | markets.businessinsider.comDGAP-News: Newron extends Senior Management team and strengthens commitment to ESGJune 7, 2022 | finance.yahoo.comNewron presents encouraging interim results for evenamide in patients with Treatment-Resistant Schizophrenia (TRS) at the 33rd CINP Hybrid World Congress of NeuropsychopharmacologyMarch 15, 2022 | markets.businessinsider.comDGAP-News: Newron announces 2021 financial results and provides outlook for 2022January 19, 2022 | nasdaq.comNewron Pharmaceuticals Spa. (NWPHF)December 1, 2021 | uk.finance.yahoo.comChange in Newron Board of DirectorsDecember 1, 2021 | markets.businessinsider.comEQS-Adhoc: Change in Newron Board of DirectorsDecember 1, 2021 | markets.businessinsider.comDGAP-News: Change in Newron Board of DirectorsOctober 18, 2021 | finance.yahoo.comNewron Receives Fifth Tranche from Financing Agreement with European Investment Bank (EIB)September 16, 2021 | finance.yahoo.comNewron Announces Half-Year 2021 ResultsSeptember 6, 2021 | finance.yahoo.comNewron Receives Fourth Tranche from Financing Agreement with European Investment Bank (EIB) Get Newron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NWPHF and its competitors with MarketBeat's FREE daily newsletter. Email Address Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad)Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble. Click here if you’d like to learn more about these five cryptos… NWPHF Media Mentions By Week NWPHF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NWPHF News Sentiment▼0.170.56▲Average Medical News Sentiment NWPHF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NWPHF Articles This Week▼20▲NWPHF Articles Average Week Get Newron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NWPHF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Incannex Healthcare News Today CervoMed News Today Cybin News Today Prelude Therapeutics News Today I-Mab News Today Skye Bioscience News Today InterCure News Today CytoDyn News Today Regulus Therapeutics News Today Elite Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:NWPHF) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCharles Payne Demystifies OptionsUnstoppable ProsperityRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe only AI company you should be looking atBehind the MarketsElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Newron Pharmaceuticals S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
